We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

113 hedge funds and large institutions have $272M invested in Rigel Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 35 increasing their positions, 30 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

155% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 11

58% more capital invested

Capital invested by funds: $172M → $272M (+$99.6M)

18% more funds holding

Funds holding: 96 → 113 (+17)

17% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 30

8% more call options, than puts

Call options by funds: $193K | Put options by funds: $179K

Holders
113
Holders Change
+17
Holders Change %
+17.71%
% of All Funds
3.01%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
28
Increased
35
Reduced
30
Closed
11
Calls
$193K
Puts
$179K
Net Calls
+$14K
Net Calls Change
+$11K

Top Buyers

1
RPAM
Rhenman & Partners Asset Management
Sweden
+$2.74M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.42M
3
OAM
Oxford Asset Management
United Kingdom
+$1.28M
4
DCM
DAFNA Capital Management
California
+$989K
5
TI
Turner Investments
Pennsylvania
+$644K

Top Sellers

1
VAM
Visium Asset Management
New York
-$1.37M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.14M
3
BACM
Blue Arrow Capital Management
New York
-$1.02M
4
Norges Bank
Norges Bank
Norway
-$960K
5
BC
Broadfin Capital
New York
-$700K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$1.3M – – –
Jacobs Levy Equity Management
27
Jacobs Levy Equity Management
New Jersey
$1.28M -$333K -12,138 -25%
BBA
28
Baker Bros. Advisors
New York
$1.27M -$342K -12,478 -26%
TC
29
TFS Capital
Pennsylvania
$1.18M +$340K +12,398 +60%
Charles Schwab
30
Charles Schwab
California
$1.05M – – –
BIM
31
BlackRock Investment Management
Delaware
$1.03M -$4.17K -152 -0.5%
AllianceBernstein
32
AllianceBernstein
Tennessee
$1.03M – – –
Two Sigma Advisers
33
Two Sigma Advisers
New York
$1.02M +$74.9K +2,730 +11%
Two Sigma Investments
34
Two Sigma Investments
New York
$961K +$3.89K +142 +0.5%
NFA
35
Nationwide Fund Advisors
Ohio
$864K +$217K +7,912 +49%
TI
36
Turner Investments
Pennsylvania
$839K +$644K +23,488 New
WMSA
37
Weiss Multi-Strategy Advisers
New York
$821K +$27.4K +1,000 +5%
T. Rowe Price Associates
38
T. Rowe Price Associates
Maryland
$793K +$13.7K +500 +2%
MOACM
39
Mutual of America Capital Management
New York
$777K – – –
TI
40
Telemetry Investments
New York
$714K -$274K -10,000 -33%
Deutsche Bank
41
Deutsche Bank
Germany
$708K -$25.7K -937 -5%
BCM
42
Bridgeway Capital Management
Texas
$705K – – –
RFC
43
Russell Frank Company
Washington
$626K -$112K -4,073 -19%
SIM
44
Spark Investment Management
New York
$584K +$377K +13,760 +525%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$570K -$5.21K -190 -1%
First Manhattan
46
First Manhattan
New York
$561K +$431K +15,737 New
Nomura Holdings
47
Nomura Holdings
Japan
$550K +$56.4K +2,057 +15%
HVC
48
Healthcare Value Capital
New Jersey
$536K -$685K -25,000 -63%
Connor, Clark & Lunn Investment Management (CC&L)
49
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$519K +$346K +12,630 +661%
USAA
50
United Services Automobile Association
Texas
$487K +$21.6K +788 +6%
1
2
3 4 5

RIGL Hedge Fund Activity: Q1 2015 in Review

113 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q1 2015, worth a combined $272M — up 58% from $172M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new RIGL positions and 11 closed out — a net gain of 17 holders — while 35 added to existing stakes and 30 trimmed.

The largest buyer was Rhenman & Partners Asset Management, opening a new position worth an estimated $2.74M. The largest seller was Visium Asset Management, exiting entirely with an estimated $1.37M sold.

  • 113 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q1 2015, up from 96 in Q4 2014.
  • Funds reported $272M of Rigel Pharmaceuticals stock for Q1 2015, up 58% quarter-over-quarter.
  • 28 funds opened new Rigel Pharmaceuticals positions in Q1 2015 and 11 closed out, a net change of +17 holders.
  • The largest Rigel Pharmaceuticals buyer in Q1 2015 was Rhenman & Partners Asset Management, an estimated $2.74M added.
  • The largest Rigel Pharmaceuticals seller in Q1 2015 was Visium Asset Management, an estimated $1.37M sold.

Based on aggregated 13F filings for Q1 2015.